Lista de obras - Stefan Hohaus - Dominio Público Uruguay

Adjuvant high-dose therapy with peripheral blood stem cell support for patients with high-risk breast cancer.

artículo científico publicado en 1999

Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin.

artículo científico publicado en 2010

Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin.

artículo científico publicado en 2013

Autografting with CD34+ peripheral blood stem cells: retained engraftment capability and reduced tumour cell content

artículo científico publicado en 1999

Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule

artículo científico publicado en 2011

Bendamustine for Hodgkin lymphoma patients failing autologous or autologous and allogeneic stem cell transplantation: a retrospective study of the Fondazione Italiana Linfomi

artículo científico publicado en 2014

Burkitt's lymphoma of the breast metastatic to the ovary diagnosed during pregnancy.

artículo científico publicado en 2013

Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias

artículo científico publicado en 2015

Clinical and prognostic features of lymphomas arising in the head and neck region: Our experience of preferential association of different histotypes with various sites of origin in ninety patients

artículo científico publicado en 2013

Clinical relevance of genomic aberrations in homogeneously treated high-risk stage II/III breast cancer patients.

artículo científico publicado en 2001

Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication

artículo científico publicado en 2015

Desensitization to thalidomide in a patient with multiple myeloma.

artículo científico publicado en 2008

Distribution, function, and prognostic value of cytotoxic T lymphocytes in follicular lymphoma: a 3-D tissue-imaging study

artículo científico publicado en 2011

Effect of recombinant human granulocyte-macrophage colony-stimulating factor (rhuGM-CSF) on normal peripheral B lymphocytes and B lymphoblastoid cell lines

scientific article published on 01 January 1989

Epigenetic changes in therapy-related MDS/AML.

artículo científico publicado en 2009

Fanconi anemia gene variants in therapy-related myeloid neoplasms.

artículo científico publicado en 2015

Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma.

artículo científico publicado en 2015

Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine

article

Genomic imbalances in circulating DNA in Hodgkin's lymphoma

artículo científico publicado en 2015

Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma

artículo científico publicado en 2007

High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study.

artículo científico publicado en 2012

High-dose therapy with peripheral blood progenitor cell transplantation in multiple myeloma

artículo científico publicado en 1997

Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience.

artículo científico publicado en 2011

In vitro effect of eltrombopag alone and in combination with azacitidine on megakaryopoiesis in patients with myelodysplastic syndrome

scientific article published on 08 April 2020

In vivo depletion of B cells using a combination of high-dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma

artículo científico publicado en 2000

Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes

scientific article published on 01 September 2007

Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma.

artículo científico publicado en 2011

Intravascular large B cell lymphoma: when lymphoma is suspected but routine diagnostic work-up is negative

artículo científico publicado en 2009

Intravascular large B-cell lymphoma presenting as slowly progressive paraparesis with normal MRI features

artículo científico publicado en 2011

Iron in Hodgkin's lymphoma.

artículo científico

Methylenetetrahydrofolate reductase polymorphisms in myelodysplastic syndromes and therapy-related myeloid neoplasms

artículo científico publicado en 2014

Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases.

artículo científico publicado en 2012

Newly proposed therapy-related myelodysplastic syndrome prognostic score predicts significant differences in overall survival and leukemia-free survival in patients treated with azacitidine.

artículo científico publicado en 2012

Outcome of therapy-related myeloid neoplasms treated with azacitidine

artículo científico publicado en 2012

Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study

artículo científico publicado en 2020

Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma

scientific article published on 01 March 2008

Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma.

artículo científico publicado en 2007

Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes

artículo científico publicado en 2008

Primary multifocal lymphoma of peripheral nervous system: case report and review of the literature

artículo científico publicado en 2014

Primary pancreatic lymphoma in a patient with maturity onset diabetes of the young type 3

artículo científico publicado en 2012

Prognostic factors in hodgkin lymphoma

artículo científico publicado en 2014

Quantification of DAPK1 promoter methylation in bone marrow and peripheral blood as a follicular lymphoma biomarker

artículo científico publicado en 2014

Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia

artículo científico publicado en 2006

Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome

artículo científico publicado en 2011

Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes.

artículo científico publicado en 2011

Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-Azacytidine

artículo científico publicado en 2011

Safety and efficacy of single-agent bendamustine after failure of brentuximab vedotin in patients with relapsed or refractory hodgkin's lymphoma: experience with 27 patients

artículo científico publicado en 2015

Small lymphocytic lymphoma in a patient with Fabry disease.

artículo científico publicado en 2012

Tandem and triple high-dose chemotherapy with autologous stem cell rescue in metastatic breast cancer

scientific article published on 01 January 1998

Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancer

scientific article published on 01 March 1997

The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes

scientific article published on 01 November 2013

The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL)

artículo científico publicado en 2019

The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue

scientific article published on 09 October 2011

The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma.

artículo científico publicado en 2011

Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis

scientific article published on 20 May 2020

Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy.

artículo científico publicado en 2017

Why methylation is not a marker predictive of response to hypomethylating agents.

scientific article published on April 2014

Lista de obras de Stefan Hohaus

Adjuvant high-dose therapy with peripheral blood stem cell support for patients with high-risk breast cancer.

Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin.

Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin.

Autografting with CD34+ peripheral blood stem cells: retained engraftment capability and reduced tumour cell content

Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule

Bendamustine for Hodgkin lymphoma patients failing autologous or autologous and allogeneic stem cell transplantation: a retrospective study of the Fondazione Italiana Linfomi

Burkitt's lymphoma of the breast metastatic to the ovary diagnosed during pregnancy.

Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias

Clinical and prognostic features of lymphomas arising in the head and neck region: Our experience of preferential association of different histotypes with various sites of origin in ninety patients

Clinical relevance of genomic aberrations in homogeneously treated high-risk stage II/III breast cancer patients.

Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication

Desensitization to thalidomide in a patient with multiple myeloma.

Distribution, function, and prognostic value of cytotoxic T lymphocytes in follicular lymphoma: a 3-D tissue-imaging study

Effect of recombinant human granulocyte-macrophage colony-stimulating factor (rhuGM-CSF) on normal peripheral B lymphocytes and B lymphoblastoid cell lines

Epigenetic changes in therapy-related MDS/AML.

Fanconi anemia gene variants in therapy-related myeloid neoplasms.

Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma.

Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine

Genomic imbalances in circulating DNA in Hodgkin's lymphoma

Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma

High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study.

High-dose therapy with peripheral blood progenitor cell transplantation in multiple myeloma

Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience.

In vitro effect of eltrombopag alone and in combination with azacitidine on megakaryopoiesis in patients with myelodysplastic syndrome

In vivo depletion of B cells using a combination of high-dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma

Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes

Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma.

Intravascular large B cell lymphoma: when lymphoma is suspected but routine diagnostic work-up is negative

Intravascular large B-cell lymphoma presenting as slowly progressive paraparesis with normal MRI features

Iron in Hodgkin's lymphoma.

Methylenetetrahydrofolate reductase polymorphisms in myelodysplastic syndromes and therapy-related myeloid neoplasms

Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases.

Newly proposed therapy-related myelodysplastic syndrome prognostic score predicts significant differences in overall survival and leukemia-free survival in patients treated with azacitidine.

Outcome of therapy-related myeloid neoplasms treated with azacitidine

Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study

Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma

Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma.

Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes

Primary multifocal lymphoma of peripheral nervous system: case report and review of the literature

Primary pancreatic lymphoma in a patient with maturity onset diabetes of the young type 3

Prognostic factors in hodgkin lymphoma

Quantification of DAPK1 promoter methylation in bone marrow and peripheral blood as a follicular lymphoma biomarker

Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia

Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome

Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes.

Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-Azacytidine

Safety and efficacy of single-agent bendamustine after failure of brentuximab vedotin in patients with relapsed or refractory hodgkin's lymphoma: experience with 27 patients

Small lymphocytic lymphoma in a patient with Fabry disease.

Tandem and triple high-dose chemotherapy with autologous stem cell rescue in metastatic breast cancer

Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancer

The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes

The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL)

The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue

The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma.

Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis

Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy.

Why methylation is not a marker predictive of response to hypomethylating agents.